Transplantation of allogeneic peripheral blood progenitor cells--the EBMT experience.
Schmitz
N
N
Department of Internal Medicine II, University of Kiel, Germany.
Bacigalupo
A
A
Labopin
M
M
Majolino
I
I
Laporte
J P
JP
Brinch
L
L
Cook
G
G
Lambertenghi-Deliliers
G
G
Lange
A
A
Rozman
C
C
Garcia-Conde
J
J
Finke
J
J
Domingo-Albos
A
A
Gratwohl
A
A
D000293:Adolescent; D000328:Adult; D001782:Blood Donors; D002066:Busulfan / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use; D004921:Erythropoietin / Q000627:therapeutic use; D005260:Female; D006086:Graft vs Host Disease / Q000453:epidemiology / Q000517:prevention & control; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006650:Histocompatibility Testing; D006801:Humans; D007938:Leukemia / Q000628:therapy; D008223:Lymphoma / Q000628:therapy; D008232:Lymphoproliferative Disorders / Q000628:therapy*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D014916:Whole-Body Irradiation
D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor; D016572:Cyclosporine; D011239:Prednisolone; D002066:Busulfan; D008727:Methotrexate